Loss of HSF1 abrogates ECM assembly by colon fibroblasts in cell culture, prevents ECM remodeling in a mouse model of inflammation-induced colon cancer, and significantly inhibits progression to colon cancer. Here, HSF1 is linked to malignant colon neoplasm.